- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Study Finds HPV Self-Sampling Could Expand Cervical Cancer Screening in Rural India - Video
Overview
A district-level study in Uttar Pradesh has shown that HPV DNA testing, combined with self-sampling and frontline health workers, can significantly improve cervical cancer screening in rural India. Published in BMC Public Health, the study was conducted in Amethi district among women aged 30-65 years. Of 23,972 eligible women identified, 10,141 underwent HPV testing, with screening uptake reaching 42%. In intervention areas, coverage increased from just 1.5% at baseline to more than 45%. Self-sampling was strongly preferred, with 83% of screened women choosing to collect their own samples. The programme used both centralized high-throughput laboratories and near point-of-care testing platforms, with HPV positivity ranging from 3.3% to 4.7%.
HPV-16 was the most common high-risk genotype, accounting for 31% of positive results. Women who tested positive underwent triage using Visual Inspection with Acetic Acid (VIA), while those with treatable lesions could receive thermal ablation at sub-district facilities. Overall, 52% of screen-positive women received local thermal ablation, regardless of the testing platform used. However, loss to follow-up remained a major challenge, particularly among women without symptoms. Researchers highlighted the role of ASHA workers, Health and Wellness Centres and digital monitoring systems in improving screening and follow-up. The findings suggest that self-sampling and flexible testing platforms could help expand cervical cancer screening through India’s existing public health system, according to Bioengineer.org.


